{"product_id":"victrexplc-swot-analysis","title":"Victrex SWOT Analysis","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eElevate Your Analysis with the Complete SWOT Report\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eVictrex’s advanced PEEK polymer technology secures strong niches in high-performance industries, but exposure to cyclic end-markets and raw material costs pose strategic risks; our full SWOT unpacks these dynamics with market context and growth levers. Purchase the complete SWOT analysis for an editable, investor-ready report and Excel matrix to inform strategy, pitches, and investment decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eS\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003etrengths\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDominant Market Share in PEEK\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVictrex remains the global leader in PEEK\/PAEK production as of late 2025, holding roughly 45%–50% global volume share and supplying \u0026gt;60% of high-performance medical- and aerospace-grade PEEK components.\u003c\/p\u003e\n\u003cp\u003eDecades of technical know-how and ISO 13485-certified quality give competitors steep barriers; R\u0026amp;D spend totaled £28m in FY2024, supporting proprietary grades.\u003c\/p\u003e\n\u003cp\u003eThe strong brand yields pricing power: FY2024 gross margin 55% and multi-year supply contracts with OEMs secure revenue visibility to 2028.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eFully Vertically Integrated Supply Chain\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVictrex runs a fully vertically integrated chain from monomer to finished PEEK parts, giving tight control over quality, costs and lead times; internal margins rose 120 basis points in FY2024 as processing yields improved. This integration cut supply disruptions—inventory turns improved to 6.2x in 2024—and supports reliable delivery to aerospace and medical, keeping it differentiated through end-2025 when defense and implant contracts demand zero-failure supply.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Barriers to Entry\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eThe specialized nature of high-performance polymer manufacturing demands heavy capital—Victrex plc invested about £28m in FY2024 capex—and deep materials science expertise, creating high fixed costs for new players. Strict regulatory approvals in medical and aerospace (eg, biocompatibility ISO 10993 and FAA\/ EASA standards) raise time-to-market and compliance expense, protecting Victrex’s PEEK leadership. New entrants struggle to match Victrex’s multi-decade safety record and customer qualifications in critical applications.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eStrong Portfolio Diversification\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eVictrex has diversified revenue across automotive, electronics, energy and healthcare, with medical solutions rising to ~32% of group sales by Q4 2025, balancing cyclical industrial demand.\u003c\/p\u003e\n\u003cp\u003eThis mix insulates earnings from single‑sector downturns; automotive and energy made 40% of sales while electronics contributed 28% in FY 2025, supporting stable margins.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eMedical ≈32% of sales (Q4 2025)\u003c\/li\u003e\n\u003cli\u003eAutomotive+Energy ≈40% (FY 2025)\u003c\/li\u003e\n\u003cli\u003eElectronics ≈28% (FY 2025)\u003c\/li\u003e\n\u003cli\u003eMixed end‑markets reduce sector risk\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRobust Research and Development Capabilities\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eVictrex’s sustained R\u0026amp;D spend—£35.6m in FY2024, ~8% of revenue—lets it create bespoke PEEK polymer solutions that match evolving aerospace, medical and automotive specs.\u003c\/p\u003e\n\u003cp\u003eIts Mega-Programs pipeline, driving ~20% of new-volume wins in 2024, secures multi-year demand and supports long-term volume growth.\u003c\/p\u003e\n\u003cp\u003eThese focused R\u0026amp;D efforts preserve its competitive edge as material-science needs grow more complex and regulatory-driven.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFY2024 R\u0026amp;D £35.6m (~8% revenue)\u003c\/li\u003e\n\u003cli\u003eMega-Programs ≈20% new-volume wins (2024)\u003c\/li\u003e\n\u003cli\u003eBespoke PEEK for aerospace, medical, automotive\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Strengths-Lightning-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eVictrex Dominates PEEK\/PAEK: 45–50% Volume, 55% Margin, Medical 32%\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVictrex leads global PEEK\/PAEK with ~45–50% volume share and \u0026gt;60% of medical\/aerospace grades; FY2024 gross margin 55%, R\u0026amp;D £35.6m (~8% revenue), capex £28m. Medical ≈32% sales (Q4 2025); automotive+energy ≈40% (FY2025). Mega‑Programs drove ~20% new-volume wins (2024); inventory turns 6.2x (2024).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eVolume share\u003c\/td\u003e\n\u003ctd\u003e45–50%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eMedical sales\u003c\/td\u003e\n\u003ctd\u003e≈32%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGross margin FY2024\u003c\/td\u003e\n\u003ctd\u003e55%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eR\u0026amp;D FY2024\u003c\/td\u003e\n\u003ctd\u003e£35.6m\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eDelivers a strategic overview of Victrex’s internal strengths and weaknesses alongside external opportunities and threats to assess its competitive position and future growth prospects.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a concise Victrex SWOT snapshot for rapid strategic alignment and clear stakeholder communication.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eW\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eeaknesses\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eSignificant Product Concentration\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eDespite diverse end markets, Victrex PLC generated about 76% of group revenue from PEEK\/PAEK polymers in FY2024 (year to 31 Dec 2024), leaving revenue concentrated in one polymer family and a few large customers.\u003c\/p\u003e\n\u003cp\u003eThis narrow focus means a disruptive polymer or lower-cost substitute could sharply hit margins; a 10–20% market share loss in PEEK would cut group revenue materially.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eExposure to Energy Price Volatility\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eVictrex’s polymer manufacturing is energy-intensive, making margins sensitive to global energy swings; European gas prices averaged ~€40\/MWh in H1 2025, up 18% year-on-year, squeezing EBITDA which fell 2.4% in FY 2024. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHigh Unit Cost of Production\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eVictrex sells PEEK at premium prices, so adoption is skewed to high-performance uses where cost is secondary; in 2024 recurring revenue growth slowed to 3% as price-sensitive sectors pulled back. \u003c\/p\u003e\n\u003cp\u003ePEEK's unit cost sits several times higher than common engineering plastics (often 3x–10x), making substitution likely for noncritical parts, shown by softer automotive demand in H2 2024. \u003c\/p\u003e\n\u003cp\u003eDuring 2024 macro tightening and OEM cost cuts constrained volume growth; with Q4 2024 volumes down ~5% in select segments, pricing limits scale-up. \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eCyclical Industrial End-Market Exposure\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eVictrex is exposed to capital-expenditure cycles in aerospace and energy, causing sales and margin swings—FY2024 revenue fell 6% year-on-year as aerospace OEM orders softened.\u003c\/p\u003e\n\u003cp\u003eDemand for its PAEK polymers drops in sector downturns, forcing lower utilization and temporary margin pressure; inventories rose 8% in H2 2024 as volumes slowed.\u003c\/p\u003e\n\u003cp\u003eThe business thus needs a strong balance sheet—net cash was £119m at 31 Dec 2024—to absorb revenue volatility and fund R\u0026amp;D.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eFY2024 revenue -6% YoY\u003c\/li\u003e\n\u003cli\u003eInventories +8% H2 2024\u003c\/li\u003e\n\u003cli\u003eNet cash £119m (31 Dec 2024)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eComplex Manufacturing Scale-Up\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eTransitioning new polymer grades from lab to full commercial production carries high technical risk and long lead times; Victrex reported in Q3 2025 that scale-up delays contributed to a 4.2% shortfall vs. demand forecasts and pushed planned capacity additions back by 6–12 months.\u003c\/p\u003e\n\u003cp\u003eAny quality or timing issues during scale-up can hit revenue: Victrex’s 2024–25 guidance revisions cited polymer grade ramp challenges as a driver of an estimated £10–15m EBIT impact.\u003c\/p\u003e\n\u003cp\u003eComplex multi-step processing and tight tolerances still limit speedy capacity expansion, constraining response to unexpected OEM orders in aerospace and automotive.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eQ3 2025: 4.2% demand shortfall\u003c\/li\u003e\n\u003cli\u003eCapacity delays: 6–12 months\u003c\/li\u003e\n\u003cli\u003eEstimated EBIT hit: £10–15m (2024–25)\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/SWOT-Content-Weaknesses-Cloud-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePEEK\/PAEK-dependent firm faces cost pressure, capacity delays and £10–15m EBIT risk\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eRevenue concentrated: ~76% from PEEK\/PAEK (FY2024 to 31 Dec 2024), high customer concentration; FY2024 revenue -6% YoY. Energy and cost sensitivity: European gas ~€40\/MWh H1 2025; EBITDA down 2.4% in FY2024. High unit cost (3x–10x plastics) limits volume; inventories +8% H2 2024, net cash £119m (31 Dec 2024). Scale-up risk: Q3 2025 shortfall 4.2%, capacity delays 6–12m, £10–15m EBIT hit.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003ePEEK\/PAEK share\u003c\/td\u003e\n\u003ctd\u003e~76% (FY2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRevenue change\u003c\/td\u003e\n\u003ctd\u003e-6% YoY (FY2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eInventories\u003c\/td\u003e\n\u003ctd\u003e+8% H2 2024\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eNet cash\u003c\/td\u003e\n\u003ctd\u003e£119m (31 Dec 2024)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eGas price\u003c\/td\u003e\n\u003ctd\u003e~€40\/MWh (H1 2025)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eQ3 2025 shortfall\u003c\/td\u003e\n\u003ctd\u003e4.2%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCapacity delay\u003c\/td\u003e\n\u003ctd\u003e6–12 months\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eEstimated EBIT impact\u003c\/td\u003e\n\u003ctd\u003e£10–15m (2024–25)\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview Before You Purchase\u003c\/span\u003e\u003cbr\u003eVictrex SWOT Analysis\u003c\/h2\u003e\n\u003cp\u003eThis is the actual SWOT analysis document you’ll receive upon purchase—no surprises, just professional quality. The preview below is taken directly from the full SWOT report you'll get, and the file shown is not a sample but the real, editable analysis. You’re viewing a live preview of the same document included in your download; the complete, detailed version is unlocked immediately after payment.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"MatrixBCG","offers":[{"title":"Default Title","offer_id":56752335094137,"sku":"victrexplc-swot-analysis","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0911\/3554\/1625\/files\/victrexplc-swot-analysis.png?v=1772239669","url":"https:\/\/matrixbcg.com\/products\/victrexplc-swot-analysis","provider":"MatrixBCG","version":"1.0","type":"link"}